{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:36:32Z","timestamp":1788561392544,"version":"build-2803163510"},"reference-count":120,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,7,27]],"date-time":"2015-07-27T00:00:00Z","timestamp":1437955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003329","name":"MINECO","doi-asserted-by":"publisher","award":["SAF-2008-00471"],"award-info":[{"award-number":["SAF-2008-00471"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"D.F.B.","award":["SAF-2011-23639"],"award-info":[{"award-number":["SAF-2011-23639"]}]},{"name":"Inflammation and Rheumatic Diseases"},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003751","name":"Ministry of Health, Social Services and Equality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"D.F.B.","award":["RD08\/0075\/0015"],"award-info":[{"award-number":["RD08\/0075\/0015"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Systemic lupus erythematosus is a chronic, multifactorial autoimmune disease of complex etiology, characterized by loss of tolerance to nuclear autoantigens, expansion of autoreactive T and B cell clones, polyclonal B cell activation that gives rise to hypergammaglobulinemia, and increased autoantibody production, as well as immune complex deposition and multiorgan tissue inflammation. As disease progresses, immune cells, mainly T cells and macrophages, infiltrate affected organs and amplify the local inflammatory response. Natural killer cells are large, granular lymphocytes that are an important link between the innate and adaptive immune systems; variations in their activity correlate with several autoimmune diseases. To date, the literature has disregarded natural killer cells as relevant modulators in systemic lupus erythematosus pathogenesis, as these cells are few in number and show a dysfunctional phenotype in patients with active systemic lupus erythematosus. This review focuses on research that could help define the role of natural killer cells in systemic lupus erythematosus and their function in regulating this autoimmune disorder in nonlymphoid organs.<\/jats:p>","DOI":"10.1189\/jlb.4ru0315-081rr","type":"journal-article","created":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T01:41:09Z","timestamp":1438047669000},"page":"479-487","source":"Crossref","is-referenced-by-count":77,"title":["Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus"],"prefix":"10.1093","volume":"98","author":[{"given":"Roberto","family":"Spada","sequence":"first","affiliation":[{"name":"Department of Immunology and Oncology, Centro Nacional de Biotecnolog\u00eda\/Consejo Superior de Investigaciones Cientificas , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M","family":"Rojas","sequence":"additional","affiliation":[{"name":"Department of Immunology and Oncology, Centro Nacional de Biotecnolog\u00eda\/Consejo Superior de Investigaciones Cientificas , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo F","family":"Barber","sequence":"additional","affiliation":[{"name":"Department of Immunology and Oncology, Centro Nacional de Biotecnolog\u00eda\/Consejo Superior de Investigaciones Cientificas , Madrid , Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,7,27]]},"reference":[{"key":"2023013012475096800_B1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.immunol.24.021605.090700","article-title":"Natural killer cell developmental pathways: a question of balance","volume":"24","author":"Di Santo","year":"2006","journal-title":"Annu. Rev. Immunol."},{"key":"2023013012475096800_B2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.molimm.2004.07.034","article-title":"Activation of NK cell cytotoxicity","volume":"42","author":"Smyth","year":"2005","journal-title":"Mol. Immunol."},{"key":"2023013012475096800_B3","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"key":"2023013012475096800_B4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1189\/jlb.71.2.173","article-title":"Role of chemokines in the biology of natural killer cells","volume":"71","author":"Robertson","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"2023013012475096800_B5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0092-8674(92)90030-G","article-title":"RAG-1-deficient mice have no mature B and T lymphocytes","volume":"68","author":"Mombaerts","year":"1992","journal-title":"Cell"},{"key":"2023013012475096800_B6","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-C","article-title":"RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement","volume":"68","author":"Shinkai","year":"1992","journal-title":"Cell"},{"key":"2023013012475096800_B7","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"2023013012475096800_B8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.coi.2005.01.005","article-title":"Distinguishing features of developing natural killer cells","volume":"17","author":"Vosshenrich","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"2023013012475096800_B9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"2023013012475096800_B10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.it.2005.02.007","article-title":"Cellular ligands of activating NK receptors","volume":"26","author":"Bottino","year":"2005","journal-title":"Trends Immunol."},{"key":"2023013012475096800_B11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/35059110","article-title":"Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells","volume":"409","author":"Mandelboim","year":"2001","journal-title":"Nature"},{"key":"2023013012475096800_B12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.1070884","article-title":"Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors","volume":"296","author":"Arase","year":"2002","journal-title":"Science"},{"key":"2023013012475096800_B13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"key":"2023013012475096800_B14","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/nri2144","article-title":"Promiscuity and the single receptor: NKG2D","volume":"7","author":"Eagle","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"2023013012475096800_B15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20081648","article-title":"Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus","volume":"206","author":"Dai","year":"2009","journal-title":"J. Exp. Med."},{"key":"2023013012475096800_B16","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1073\/pnas.1632807100","article-title":"Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis","volume":"100","author":"Groh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023013012475096800_B17","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1073\/pnas.0601335103","article-title":"Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis","volume":"103","author":"Bielekova","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023013012475096800_B18","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1073\/pnas.0700442104","article-title":"Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients","volume":"104","author":"Dotta","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023013012475096800_B19","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1053\/j.gastro.2007.03.025","article-title":"CD4+NKG2D+ T cells in Crohn\u2019s disease mediate inflammatory and cytotoxic responses through MICA interactions","volume":"132","author":"Allez","year":"2007","journal-title":"Gastroenterology"},{"key":"2023013012475096800_B20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.autrev.2008.03.002","article-title":"NK cells in autoimmunity: a two-edg\u2019d weapon of the immune system","volume":"7","author":"Perricone","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"2023013012475096800_B21","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awh219","article-title":"The regulatory role of natural killer cells in multiple sclerosis","volume":"127","author":"Takahashi","year":"2004","journal-title":"Brain"},{"key":"2023013012475096800_B22","doi-asserted-by":"crossref","first-page":"R23","DOI":"10.1172\/JCI11819","article-title":"Natural killer type 2 bias in remission of multiple sclerosis","volume":"107","author":"Takahashi","year":"2001","journal-title":"J. Clin. Invest."},{"key":"2023013012475096800_B23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fimmu.2013.00063","article-title":"The role of natural killer cells in multiple sclerosis and their therapeutic implications","volume":"4","author":"Chanvillard","year":"2013","journal-title":"Front. Immunol."},{"key":"2023013012475096800_B24","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2353\/ajpath.2009.080945","article-title":"Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models","volume":"175","author":"Chen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"2023013012475096800_B25","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.4049\/jimmunol.178.9.5496","article-title":"Kruppel-like transcription factor 13 regulates T lymphocyte survival in vivo","volume":"178","author":"Zhou","year":"2007","journal-title":"J. Immunol."},{"key":"2023013012475096800_B26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/db06-0493","article-title":"Altered natural killer cells in type 1 diabetic patients","volume":"56","author":"Rodacki","year":"2007","journal-title":"Diabetes"},{"key":"2023013012475096800_B27","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2567.2007.02638.x","article-title":"Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94\/NKG2A in control of cytokine secretion","volume":"122","author":"De Matos","year":"2007","journal-title":"Immunology"},{"key":"2023013012475096800_B28","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/art.10410","article-title":"A subset of natural killer cells is greatly expanded within inflamed joints","volume":"46","author":"Dalbeth","year":"2002","journal-title":"Arthritis Rheum."},{"key":"2023013012475096800_B29","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1053\/j.gastro.2010.05.040","article-title":"Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn\u2019s disease","volume":"139","author":"Takayama","year":"2010","journal-title":"Gastroenterology"},{"key":"2023013012475096800_B30","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/art.24531","article-title":"Systemic lupus erythematosus: a matter of life and death","volume":"60","author":"Pisetsky","year":"2009","journal-title":"Arthritis Rheum."},{"key":"2023013012475096800_B31","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1056\/NEJM199406303302608","article-title":"Systemic lupus erythematosus","volume":"330","author":"Mills","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"2023013012475096800_B32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0092-8674(00)81108-3","article-title":"Systemic lupus erythematosus","volume":"85","author":"Kotzin","year":"1996","journal-title":"Cell"},{"key":"2023013012475096800_B33","first-page":"269","article-title":"Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin","volume":"6","author":"Inghirami","year":"1988","journal-title":"Clin. Exp. Rheumatol."},{"key":"2023013012475096800_B34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/ard.62.5.431","article-title":"Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy","volume":"62","author":"Cervera","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"2023013012475096800_B35","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4049\/jimmunol.1400350","article-title":"Inhibition of PI3K\u03b4 reduces kidney infiltration by macrophages and ameliorates systemic lupus in the mouse","volume":"193","author":"Su\u00e1rez-Fueyo","year":"2014","journal-title":"J. Immunol."},{"key":"2023013012475096800_B36","first-page":"849684","article-title":"Lupus nephritis: an overview of recent findings","volume":"2012","author":"De Zubiria Salgado","year":"2012","journal-title":"Autoimmune Dis."},{"key":"2023013012475096800_B37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/art.22224","article-title":"Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual","volume":"55","author":"Vil\u00e1","year":"2006","journal-title":"Arthritis Rheum."},{"key":"2023013012475096800_B38","first-page":"74","article-title":"Anti-T cell antibodies in primary glomerulonephritis","volume":"23","author":"Nakabayashi","year":"1985","journal-title":"Clin. Nephrol."},{"key":"2023013012475096800_B39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/ard.52.1.14","article-title":"Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology","volume":"52","author":"Okamura","year":"1993","journal-title":"Ann. Rheum. Dis."},{"key":"2023013012475096800_B40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<339::AID-IMMU339>3.0.CO;2-C","article-title":"Genetic, structural and functional properties of an IgG DNA-binding monoclonal antibody from a lupus patient with nephritis","volume":"28","author":"Ravirajan","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"2023013012475096800_B41","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/art.24556","article-title":"Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus","volume":"60","author":"Park","year":"2009","journal-title":"Arthritis Rheum."},{"key":"2023013012475096800_B42","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.4049\/jimmunol.1000569","article-title":"Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus","volume":"186","author":"Huang","year":"2011","journal-title":"J. Immunol."},{"key":"2023013012475096800_B43","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/096120339700600905","article-title":"Lack of NK cells in lupus patients with renal involvement","volume":"6","author":"Erkeller-Yuksel","year":"1997","journal-title":"Lupus"},{"key":"2023013012475096800_B44","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0307-742X(21)00602-0","article-title":"Natural killer cells in connective tissue disorders","volume":"11","author":"Sibbitt","year":"1985","journal-title":"Clin. Rheum. Dis."},{"key":"2023013012475096800_B45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-5728(98)00014-9","article-title":"A role for natural killer cells in the immunopathogenesis of multiple sclerosis","volume":"86","author":"Kastrukoff","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"2023013012475096800_B46","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/art.30313","article-title":"Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-\u03b3 production in patients with active disease","volume":"63","author":"Hervier","year":"2011","journal-title":"Arthritis Rheum."},{"key":"2023013012475096800_B47","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3109\/03009742.2011.648657","article-title":"Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases","volume":"41","author":"Puxeddu","year":"2012","journal-title":"Scand. J. Rheumatol."},{"key":"2023013012475096800_B48","volume-title":"Int. J. Rheum. Dis","author":"Ye","year":"2014"},{"key":"2023013012475096800_B49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2567.2008.02887.x","article-title":"Increased proportion of CD56bright natural killer cells in active and inactive systemic lupus erythematosus","volume":"126","author":"Schepis","year":"2009","journal-title":"Immunology"},{"key":"2023013012475096800_B50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10067-009-1322-9","article-title":"Assay of T- and NK-cell subsets and the expression of NKG2A and NKG2D in patients with new-onset systemic lupus erythematosus","volume":"29","author":"Li","year":"2010","journal-title":"Clin. Rheumatol."},{"key":"2023013012475096800_B51","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.22.012703.104711","article-title":"The dynamic life of natural killer cells","volume":"22","author":"Yokoyama","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"2023013012475096800_B52","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.4049\/jimmunol.157.10.4282","article-title":"IL-15 can substitute for the marrow microenvironment in the differentiation of natural killer cells","volume":"157","author":"Puzanov","year":"1996","journal-title":"J. Immunol."},{"key":"2023013012475096800_B53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1600-065X.2006.00451.x","article-title":"Human natural killer cell development","volume":"214","author":"Freud","year":"2006","journal-title":"Immunol. Rev."},{"key":"2023013012475096800_B54","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.176.3.1517","article-title":"CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity","volume":"176","author":"Hayakawa","year":"2006","journal-title":"J. Immunol."},{"key":"2023013012475096800_B55","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/ni796","article-title":"In vivo developmental stages in murine natural killer cell maturation","volume":"3","author":"Kim","year":"2002","journal-title":"Nat. Immunol."},{"key":"2023013012475096800_B56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.2006.00454.x","article-title":"Functional subsets of mouse natural killer cells","volume":"214","author":"Hayakawa","year":"2006","journal-title":"Immunol. Rev."},{"key":"2023013012475096800_B57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1365-2567.2011.03446.x","article-title":"CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells","volume":"133","author":"Fu","year":"2011","journal-title":"Immunology"},{"key":"2023013012475096800_B58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-3083.1986.tb03073.x","article-title":"Altered natural killer and natural cytotoxic cellular activities in lpr mice","volume":"23","author":"Pan","year":"1986","journal-title":"Scand. J. Immunol."},{"key":"2023013012475096800_B59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jim.2004.08.008","article-title":"CD107a as a functional marker for the identification of natural killer cell activity","volume":"294","author":"Alter","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"2023013012475096800_B60","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"2023013012475096800_B61","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4049\/jimmunol.168.3.1146","article-title":"Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1","volume":"168","author":"Nakahira","year":"2002","journal-title":"J. Immunol."},{"key":"2023013012475096800_B62","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1084\/jem.186.9.1451","article-title":"Antinuclear autoantibodies and lupus nephritis in transgenic mice expressing interferon gamma in the epidermis","volume":"186","author":"Seery","year":"1997","journal-title":"J. Exp. Med."},{"key":"2023013012475096800_B63","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2014.02.003","article-title":"IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice","volume":"53","author":"Hodge","year":"2014","journal-title":"J. Autoimmun."},{"key":"2023013012475096800_B64","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.4049\/jimmunol.1003349","article-title":"IFN-\u03b1 production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1\u03b2 and LFA-1","volume":"186","author":"Hagberg","year":"2011","journal-title":"J. Immunol."},{"key":"2023013012475096800_B65","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s10067-013-2176-8","article-title":"NK cells dysfunction in systemic lupus erythematosus: relation to disease activity","volume":"32","author":"Henriques","year":"2013","journal-title":"Clin. Rheumatol."},{"key":"2023013012475096800_B66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbmt.2010.08.014","article-title":"Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen","volume":"17","author":"Ohata","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"2023013012475096800_B67","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"2023013012475096800_B68","doi-asserted-by":"crossref","first-page":"s33","DOI":"10.1177\/096120330501400107","article-title":"Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide","volume":"14","author":"Contreras","year":"2005","journal-title":"Lupus"},{"key":"2023013012475096800_B69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0897.2007.00574.x","article-title":"Prednisolone suppresses NK cell cytotoxicity in vitro in women with a history of infertility and elevated NK cell cytotoxicity","volume":"59","author":"Thum","year":"2008","journal-title":"Am. J. Reprod. Immunol."},{"key":"2023013012475096800_B70","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00262-014-1556-5","article-title":"Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy","volume":"63","author":"Brehm","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"issue":"2: Suppl 1","key":"2023013012475096800_B71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(10)80012-5","article-title":"Mechanism of action of hydroxychloroquine as an antirheumatic drug","volume":"23","author":"Fox","year":"1993","journal-title":"Semin. Arthritis Rheum."},{"key":"2023013012475096800_B72","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0049-0172(87)90014-X","article-title":"Immunomodulatory treatment in patients with rheumatic diseases: mechanisms of action","volume":"17","author":"Tsokos","year":"1987","journal-title":"Semin. Arthritis Rheum."},{"key":"2023013012475096800_B73","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10067-014-2712-1","article-title":"Dynamic changes in the numbers of different subsets of peripheral blood NK cells in patients with systemic lupus erythematosus following classic therapy","volume":"33","author":"Ma","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"2023013012475096800_B74","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nri3065","article-title":"Organ-specific features of natural killer cells","volume":"11","author":"Shi","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"2023013012475096800_B75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/ar1034","article-title":"Natural killer cells and autoimmunity","volume":"6","author":"French","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"2023013012475096800_B76","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1568-9972(03)00062-4","article-title":"Genetic basis of murine lupus","volume":"3","author":"Santiago-Raber","year":"2004","journal-title":"Autoimmun. Rev."},{"key":"2023013012475096800_B77","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1189\/jlb.4A0714-326R","article-title":"NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery","volume":"97","author":"Spada","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"2023013012475096800_B78","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.1402673","article-title":"Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus","volume":"194","author":"Voynova","year":"2015","journal-title":"J. Immunol."},{"key":"2023013012475096800_B79","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1046\/j.1365-2249.1996.d01-787.x","article-title":"Enhanced natural but diminished antibody-mediated cytotoxicity in the lungs of MRLlpr\/lpr mice","volume":"105","author":"Nilsson","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"2023013012475096800_B80","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.166.1.271","article-title":"High hepatic natural killer cell activity in murine lupus","volume":"166","author":"Magilavy","year":"1987","journal-title":"J. Exp. Med."},{"key":"2023013012475096800_B81","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1365-2567.2008.02835.x","article-title":"Long-term administration of IgG2a anti-NK1.1 monoclonal antibody ameliorates lupus-like disease in NZB\/W mice in spite of an early worsening induced by an IgG2a-dependent BAFF\/BLyS production","volume":"125","author":"Post\u00f3l","year":"2008","journal-title":"Immunology"},{"key":"2023013012475096800_B82","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"2023013012475096800_B83","first-page":"864","article-title":"Monocyte chemoattractant protein-1 expression in renal tissue is associated with monocyte recruitment and tubulo-interstitial lesions in patients with lupus nephritis","volume":"114","author":"Dai","year":"2001","journal-title":"Chin. Med. J. (Engl.)"},{"key":"2023013012475096800_B84","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.4049\/jimmunol.172.6.3913","article-title":"Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL\/MpJ-Fas(lpr) mice","volume":"172","author":"Sekine","year":"2004","journal-title":"J. Immunol."},{"key":"2023013012475096800_B85","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000184012","article-title":"Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis","volume":"44","author":"Park","year":"1986","journal-title":"Nephron"},{"key":"2023013012475096800_B86","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10157-004-0338-3","article-title":"Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis","volume":"9","author":"Mori","year":"2005","journal-title":"Clin. Exp. Nephrol."},{"key":"2023013012475096800_B87","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.4049\/jimmunol.181.11.7489","article-title":"NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury","volume":"181","author":"Zhang","year":"2008","journal-title":"J. Immunol."},{"key":"2023013012475096800_B88","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/TP.0000000000000665","article-title":"Natural killer cells mediate long-term kidney allograft injury","volume":"99","author":"Zhang","year":"2015","journal-title":"Transplantation"},{"key":"2023013012475096800_B89","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2011.11.016","article-title":"The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation","volume":"36","author":"Gordon","year":"2012","journal-title":"Immunity"},{"key":"2023013012475096800_B90","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.20131560","article-title":"T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow","volume":"211","author":"Daussy","year":"2014","journal-title":"J. Exp. Med."},{"key":"2023013012475096800_B91","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2014.00217","article-title":"Characterization of T-bet and eomes in peripheral human immune cells","volume":"5","author":"Knox","year":"2014","journal-title":"Front. Immunol."},{"key":"2023013012475096800_B92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nri1901","article-title":"The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design","volume":"6","author":"Waldmann","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"2023013012475096800_B93","doi-asserted-by":"crossref","first-page":"740619","DOI":"10.1155\/2010\/740619","article-title":"The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity","volume":"2010","author":"Lieberman","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"2023013012475096800_B94","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1084\/jem.154.5.1671","article-title":"Deficient interleukin 2 activity in MRL\/Mp and C57BL\/6J mice bearing the lpr gene","volume":"154","author":"Wofsy","year":"1981","journal-title":"J. Exp. Med."},{"key":"2023013012475096800_B95","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.127.6.2483","article-title":"Interleukin 2 deficiency is a common feature of autoimmune mice","volume":"127","author":"Dauphin\u00e9e","year":"1981","journal-title":"J. Immunol."},{"key":"2023013012475096800_B96","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-\u03b1 blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Sade-Feldman","year":"2013","journal-title":"Immunity"},{"key":"2023013012475096800_B97","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/intimm\/8.6.939","article-title":"Natural killer cell development is blocked in the context of aberrant T lymphocyte ontogeny","volume":"8","author":"Wang","year":"1996","journal-title":"Int. Immunol."},{"key":"2023013012475096800_B98","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/art.34483","article-title":"Large-scale analysis of tumor necrosis factor \u03b1 levels in systemic lupus erythematosus","volume":"64","author":"Weckerle","year":"2012","journal-title":"Arthritis Rheum."},{"key":"2023013012475096800_B99","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.lab.2006.01.001","article-title":"Characterization of peripheral natural killer cells in primary Sj\u00f6gren\u2019s syndrome: impaired NK cell activity and low NK cell number","volume":"147","author":"Izumi","year":"2006","journal-title":"J. Lab. Clin. Med."},{"key":"2023013012475096800_B100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/ki.1995.14","article-title":"Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms","volume":"47","author":"Yokoyama","year":"1995","journal-title":"Kidney Int."},{"key":"2023013012475096800_B101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/intimm\/dxh001","article-title":"Differential regulation of NK cell proliferation by type I and type II IFN","volume":"16","author":"Loza","year":"2004","journal-title":"Int. Immunol."},{"key":"2023013012475096800_B102","doi-asserted-by":"crossref","first-page":"e111302","DOI":"10.1371\/journal.pone.0111302","article-title":"Role of type I interferon receptor signaling on NK cell development and functions","volume":"9","author":"Guan","year":"2014","journal-title":"PLoS One"},{"key":"2023013012475096800_B103","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2009.11.001","article-title":"Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice","volume":"34","author":"Santiago-Raber","year":"2010","journal-title":"J. Autoimmun."},{"key":"2023013012475096800_B104","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crisp\u00edn","year":"2008","journal-title":"J. Immunol."},{"key":"2023013012475096800_B105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ni1353","article-title":"Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases","volume":"7","author":"Caraux","year":"2006","journal-title":"Nat. Immunol."},{"key":"2023013012475096800_B106","doi-asserted-by":"crossref","first-page":"R146","DOI":"10.1186\/ar3088","article-title":"TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus","volume":"12","author":"Suh","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"2023013012475096800_B107","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/rheumatology\/keq459","article-title":"Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus","volume":"50","author":"Ekman","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2023013012475096800_B108","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fimmu.2015.00097","article-title":"NKG2D ligands in tumor immunity: two sides of a coin","volume":"6","author":"Zhang","year":"2015","journal-title":"Front. Immunol."},{"key":"2023013012475096800_B109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/rheumatology\/keh459","article-title":"Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus","volume":"44","author":"Gambelunghe","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"2023013012475096800_B110","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/art.30501","article-title":"Role of the MICA polymorphism in systemic lupus erythematosus","volume":"63","author":"Yoshida","year":"2011","journal-title":"Arthritis Rheum."},{"key":"2023013012475096800_B111","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1074-7613(00)80664-0","article-title":"IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation","volume":"9","author":"Lodolce","year":"1998","journal-title":"Immunity"},{"key":"2023013012475096800_B112","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1084\/jem.185.3.499","article-title":"Abnormal development of intestinal intraepithelial lymphocytes and peripheral natural killer cells in mice lacking the IL-2 receptor beta chain","volume":"185","author":"Suzuki","year":"1997","journal-title":"J. Exp. Med."},{"key":"2023013012475096800_B113","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.191.5.771","article-title":"Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice","volume":"191","author":"Kennedy","year":"2000","journal-title":"J. Exp. Med."},{"key":"2023013012475096800_B114","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/rheumatology\/40.8.876","article-title":"Serum interleukin-15 is elevated in systemic lupus erythematosus","volume":"40","author":"Aringer","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"2023013012475096800_B115","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/kei083","article-title":"IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus","volume":"44","author":"Baranda","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"2023013012475096800_B116","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-3083.2008.02197.x","article-title":"Elevated expression of transmembrane IL-15 in immune cells correlates with the development of murine lupus: a potential target for immunotherapy against SLE","volume":"69","author":"Bo","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"2023013012475096800_B117","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-2249.1999.00862.x","article-title":"Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)\u2013relation to Th1- and Th2-derived cytokines","volume":"116","author":"Tokano","year":"1999","journal-title":"Clin. Exp. Immunol."},{"key":"2023013012475096800_B118","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1002\/art.10441","article-title":"Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice","volume":"46","author":"Yoshida","year":"2002","journal-title":"Arthritis Rheum."},{"key":"2023013012475096800_B119","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.4049\/jimmunol.1301022","article-title":"Systemic lupus erythematosus immune complexes increase the expression of SLAM family members CD319 (CRACC) and CD229 (LY-9) on plasmacytoid dendritic cells and CD319 on CD56(dim) NK cells","volume":"191","author":"Hagberg","year":"2013","journal-title":"J. Immunol."},{"key":"2023013012475096800_B120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2249.2010.04116.x","article-title":"Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus","volume":"160","author":"Kim","year":"2010","journal-title":"Clin. Exp. Immunol."}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/98\/4\/479\/48175452\/jlb0479.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/98\/4\/479\/48175452\/jlb0479.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T13:36:19Z","timestamp":1677504979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/98\/4\/479\/6935965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,27]]},"references-count":120,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,7,27]]},"published-print":{"date-parts":[[2015,10,1]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.4ru0315-081rr","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,10]]},"published":{"date-parts":[[2015,7,27]]}}}